Giraudo Bryan

COO/CFOGossamer Bio, Inc. (GOSS) · full profile →Form 4 · filed Mar 20, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
22
0 non-derivative · 22 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 19, 2026Disposed to issuer(D)694K0
Mar 19, 2026Disposed to issuer(D)638K0
Mar 19, 2026Disposed to issuer(D)544K0
Mar 19, 2026Disposed to issuer(D)181K0
Mar 19, 2026Disposed to issuer(D)212K0
Mar 19, 2026Disposed to issuer(D)212K0
Mar 19, 2026Disposed to issuer(D)177K0
Mar 19, 2026Disposed to issuer(D)100K0
Mar 19, 2026Disposed to issuer(D)60K0
Mar 19, 2026Disposed to issuer(D)48K0
Mar 19, 2026Disposed to issuer(D)97K0
Mar 19, 2026Grant(A)694K694K
Mar 19, 2026Grant(A)638K638K
Mar 19, 2026Grant(A)544K544K
Mar 19, 2026Grant(A)181K181K
Mar 19, 2026Grant(A)212K212K
Mar 19, 2026Grant(A)212K212K
Mar 19, 2026Grant(A)177K177K
Mar 19, 2026Grant(A)100K100K
Mar 19, 2026Grant(A)60K60K
Mar 19, 2026Grant(A)48K48K
Mar 19, 2026Grant(A)97K97K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001740847-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly: